Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jure Murgic

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2014
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab RadioimmunotherapyYuni K Dewaraja, Matthew J Schipper, Jincheng Shen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2017
Curative Radiation Therapy at Time of Progression Under Active Surveillance Compared With Up-front Radical Radiation Therapy for Prostate CancerAlejandro Berlin, Ardalan E Ahmad, Melvin L K Chua, et al.
European Urology Oncology|July 2, 2020
Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate CancerHarry C Brastianos, Jure Murgic, Adriana Salcedo, et al.
Radiation Oncology (London, England)|May 13, 2021
Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experienceJure Murgic, Blanka Jaksic, Marin Prpic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapyHamid Raziee, Fabio Y Moraes, Jure Murgic, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2018
Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone TherapyAlejandro Berlin, Jure Murgic, Ali Hosni, et al.
JCO Oncology Practice|February 13, 2020
Oncologist Burnout Syndrome in Eastern Europe: Results of the Multinational SurveyDavor Kust, Jure Murgic, Petra Vukovic, et al.
European Urology|November 6, 2016
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate TumorsEmilie Lalonde, Rached Alkallas, Melvin Lee Kiang Chua, et al.
European Urology|May 18, 2017
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform SubpathologiesMelvin L K Chua, Winnie Lo, Melania Pintilie, et al.
The Journal of Urology|January 24, 2020
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective StudyNatalie J Miller, Ali Raza Khaki, Leonidas N Diamantopoulos, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2014
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab RadioimmunotherapyYuni K Dewaraja, Matthew J Schipper, Jincheng Shen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2017
Curative Radiation Therapy at Time of Progression Under Active Surveillance Compared With Up-front Radical Radiation Therapy for Prostate CancerAlejandro Berlin, Ardalan E Ahmad, Melvin L K Chua, et al.
European Urology Oncology|July 2, 2020
Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate CancerHarry C Brastianos, Jure Murgic, Adriana Salcedo, et al.
Radiation Oncology (London, England)|May 13, 2021
Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experienceJure Murgic, Blanka Jaksic, Marin Prpic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapyHamid Raziee, Fabio Y Moraes, Jure Murgic, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2018
Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone TherapyAlejandro Berlin, Jure Murgic, Ali Hosni, et al.
JCO Oncology Practice|February 13, 2020
Oncologist Burnout Syndrome in Eastern Europe: Results of the Multinational SurveyDavor Kust, Jure Murgic, Petra Vukovic, et al.
European Urology|November 6, 2016
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate TumorsEmilie Lalonde, Rached Alkallas, Melvin Lee Kiang Chua, et al.
European Urology|May 18, 2017
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform SubpathologiesMelvin L K Chua, Winnie Lo, Melania Pintilie, et al.
The Journal of Urology|January 24, 2020
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective StudyNatalie J Miller, Ali Raza Khaki, Leonidas N Diamantopoulos, et al.
Pageof 3